Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Altman

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Bioethics|March 8, 2021
A consequentialist argument for considering age in triage decisions during the coronavirus pandemicMatthew C Altman
American Journal of Respiratory and Critical Care Medicine|May 16, 2017
A Deep Dive into Asthma Transcriptomics. Lessons from U-BIOPREDMatthew C Altman, William W Busse
The Medical Clinics of North America|May 29, 2016
Pharmacologic Therapies in Pulmonology and AllergyAndrew G Ayars, Matthew C Altman
The Journal of Allergy and Clinical Immunology|April 14, 2019
ReplyMatthew C Altman, James E Gern
Nature Immunology|September 17, 2021
Ignition sequence start: epithelial allergen sensing and regulation of the allergic inflammatory responseRyan C Murphy, Matthew C Altman
JAMA Pediatrics|November 3, 2025
Reframing Residual Inflammatory Pathways in Pediatric Asthma-ReplyMatthew C Altman, Daniel J Jackson
The Journal of Allergy and Clinical Immunology|June 28, 2018
ReplyMatthew C Altman, James E Gern
The New England Journal of Medicine|June 28, 2013
Omalizumab for chronic urticariaMatthew C Altman, David R Naimi
The Journal of Allergy and Clinical Immunology|October 6, 2023
Protective mechanisms of allergic asthma in COVID-19Naresh Doni Jayavelu, Daniel J Jackson, Matthew C Altman
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2017
Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosisMatthew C Altman, Jake Lenington, Steve Bronson, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Bioethics|March 8, 2021
A consequentialist argument for considering age in triage decisions during the coronavirus pandemicMatthew C Altman
American Journal of Respiratory and Critical Care Medicine|May 16, 2017
A Deep Dive into Asthma Transcriptomics. Lessons from U-BIOPREDMatthew C Altman, William W Busse
The Medical Clinics of North America|May 29, 2016
Pharmacologic Therapies in Pulmonology and AllergyAndrew G Ayars, Matthew C Altman
The Journal of Allergy and Clinical Immunology|April 14, 2019
ReplyMatthew C Altman, James E Gern
Nature Immunology|September 17, 2021
Ignition sequence start: epithelial allergen sensing and regulation of the allergic inflammatory responseRyan C Murphy, Matthew C Altman
JAMA Pediatrics|November 3, 2025
Reframing Residual Inflammatory Pathways in Pediatric Asthma-ReplyMatthew C Altman, Daniel J Jackson
The Journal of Allergy and Clinical Immunology|June 28, 2018
ReplyMatthew C Altman, James E Gern
The New England Journal of Medicine|June 28, 2013
Omalizumab for chronic urticariaMatthew C Altman, David R Naimi
The Journal of Allergy and Clinical Immunology|October 6, 2023
Protective mechanisms of allergic asthma in COVID-19Naresh Doni Jayavelu, Daniel J Jackson, Matthew C Altman
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2017
Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosisMatthew C Altman, Jake Lenington, Steve Bronson, et al.
Pageof 12